175 related articles for article (PubMed ID: 28981551)
1. Predictors of HPV incidence and clearance in a cohort of Brazilian HIV-infected women.
Travassos AG; Netto E; Xavier-Souza E; Nóbrega I; Adami K; Timbó M; Abbehusen K; Fernandes S; Duran C; Haguihara T; Ferreira F; Brites C
PLoS One; 2017; 12(10):e0185423. PubMed ID: 28981551
[TBL] [Abstract][Full Text] [Related]
2. High-risk papillomavirus infection among women living with human Immunodeficiency virus: Brazilian multicentric study.
Miranda AE; Silveira MF; Travassos AG; Tenório T; Val ICC; Lannoy L; Mattos Junior HS; Carvalho NS
J Med Virol; 2017 Dec; 89(12):2217-2223. PubMed ID: 28771777
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of high-risk human papillomavirus and cervical lesions in African women living with HIV/AIDS: effect of anti-retroviral therapy.
Kelly HA; Sawadogo B; Chikandiwa A; Segondy M; Gilham C; Lompo O; Omar T; Didelot MN; Nagot N; Meda N; Weiss HA; Delany-Moretlwe S; Mayaud P;
AIDS; 2017 Jan; 31(2):273-285. PubMed ID: 27755107
[TBL] [Abstract][Full Text] [Related]
4. High risk human papillomavirus prevalence and genotype distribution among women infected with HIV in Manaus, Amazonas.
Teixeira MF; Sabidó M; Leturiondo AL; de Oliveira Ferreira C; Torres KL; Benzaken AS
Virol J; 2018 Feb; 15(1):36. PubMed ID: 29454382
[TBL] [Abstract][Full Text] [Related]
5. Sustained viral suppression and higher CD4+ T-cell count reduces the risk of persistent cervical high-risk human papillomavirus infection in HIV-positive women.
Konopnicki D; Manigart Y; Gilles C; Barlow P; de Marchin J; Feoli F; Larsimont D; Delforge M; De Wit S; Clumeck N
J Infect Dis; 2013 Jun; 207(11):1723-9. PubMed ID: 23463709
[TBL] [Abstract][Full Text] [Related]
6. Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study.
Luckett R; Painter H; Hacker MR; Simon B; Seiphetlheng A; Erlinger A; Eakin C; Moyo S; Kyokunda LT; Esselen K; Feldman S; Morroni C; Ramogola-Masire D
BJOG; 2021 Nov; 128(12):1986-1996. PubMed ID: 34008294
[TBL] [Abstract][Full Text] [Related]
7. Transitional probability-based model for HPV clearance in HIV-1-positive adolescent females.
Kravchenko J; Akushevich I; Sudenga SL; Wilson CM; Levitan EB; Shrestha S
PLoS One; 2012; 7(1):e30736. PubMed ID: 22292027
[TBL] [Abstract][Full Text] [Related]
8. Anal and oral human papillomavirus (HPV) infection in HIV-infected subjects in northern Italy: a longitudinal cohort study among men who have sex with men.
Parisi SG; Cruciani M; Scaggiante R; Boldrin C; Andreis S; Dal Bello F; Pagni S; Barelli A; Sattin A; Mengoli C; Palù G
BMC Infect Dis; 2011 May; 11():150. PubMed ID: 21612634
[TBL] [Abstract][Full Text] [Related]
9. Anal human papillomavirus (HPV) prevalences and factors associated with abnormal anal cytology in HIV-infected women in an urban cohort from Rio de Janeiro, Brazil.
Cambou MC; Luz PM; Lake JE; Levi JE; Coutinho JR; de Andrade A; Heinke T; Derrico M; Veloso VG; Friedman RK; Grinsztejn B
AIDS Patient Care STDS; 2015 Jan; 29(1):4-12. PubMed ID: 25361401
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus prevalence, viral load and pre-cancerous lesions of the cervix in women initiating highly active antiretroviral therapy in South Africa: a cross-sectional study.
Moodley JR; Constant D; Hoffman M; Salimo A; Allan B; Rybicki E; Hitzeroth I; Williamson AL
BMC Cancer; 2009 Aug; 9():275. PubMed ID: 19664216
[TBL] [Abstract][Full Text] [Related]
11. High Prevalence of Cervical High-Grade Lesions and High-Risk Human Papillomavirus Infections in Women Living with HIV: A Case for Prioritizing Cervical Screening in This Vulnerable Group.
Gupta R; Hussain S; Hariprasad R; Dhanasekaran K; Verma S; Agarwal V; Sandeep ; Parveen S; Kaur A; Verma CP; Amita ; Dwivedi R; Singh S; Gupta S
Acta Cytol; 2022; 66(6):496-506. PubMed ID: 35760059
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of HPV infection over time in European women who are HIV-1 positive.
Heard I; Cubie HA; Mesher D; Sasieni P;
BJOG; 2013 Jan; 120(1):41-9. PubMed ID: 23121095
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, Incidence, and Clearance of Human Papillomavirus Types Covered by Current Vaccines in Men With Human Immunodeficiency Virus in the SUN Study.
Patel P; Bush T; Conley L; Unger ER; Darragh TM; Henry K; Escota G; Brooks JT; Kojic EM
J Infect Dis; 2020 Jun; 222(2):234-242. PubMed ID: 31536120
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study).
Kojic EM; Cu-Uvin S; Conley L; Bush T; Onyekwuluje J; Swan DC; Unger ER; Henry K; Hammer JH; Overton ET; Darragh TM; Palefsky JM; Vellozzi C; Patel P; Brooks JT
Sex Transm Dis; 2011 Apr; 38(4):253-9. PubMed ID: 20966828
[TBL] [Abstract][Full Text] [Related]
15. Incidence, Persistence, Clearance, and Correlates of Genital Human Papillomavirus Infection and Anogenital Warts in a Cohort of Men Living With Human Immunodeficiency Virus in South Africa.
Chikandiwa A; Pisa PT; Muller EE; Tamalet C; Mayaud P; Chersich MF; Delany-Moretlwe S
Sex Transm Dis; 2019 May; 46(5):347-353. PubMed ID: 30985636
[TBL] [Abstract][Full Text] [Related]
16. Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women's interagency HIV study.
Massad LS; Ahdieh L; Benning L; Minkoff H; Greenblatt RM; Watts H; Miotti P; Anastos K; Moxley M; Muderspach LI; Melnick S
J Acquir Immune Defic Syndr; 2001 Aug; 27(5):432-42. PubMed ID: 11511819
[TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus and abnormal cervical lesions among HIV-infected women in HIV-discordant couples from Kenya.
Guthrie BL; Rositch AF; Cooper JA; Farquhar C; Bosire R; Choi R; Kiarie J; Smith JS
Sex Transm Infect; 2020 Sep; 96(6):457-463. PubMed ID: 31919275
[TBL] [Abstract][Full Text] [Related]
18. High prevalence and incidence of HPV-related anal cancer precursor lesions in HIV-positive women in the late HAART era.
Hidalgo-Tenorio C; de Jesus SE; Esquivias J; Pasquau J
Enferm Infecc Microbiol Clin (Engl Ed); 2018 Nov; 36(9):555-562. PubMed ID: 29208455
[TBL] [Abstract][Full Text] [Related]
19. Natural history of human papillomavirus infections involving anal, penile, and oral sites among HIV-positive men.
Videla S; Darwich L; Cañadas MP; Coll J; Piñol M; García-Cuyás F; Molina-Lopez RA; Cobarsi P; Clotet B; Sirera G;
Sex Transm Dis; 2013 Jan; 40(1):3-10. PubMed ID: 23250297
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1-infected women without history of cervical pathology.
Videla S; Darwich L; Cañadas MP; Paredes R; Tarrats A; Castella E; Llatjos M; Bofill M; Clotet B; Sirera G;
J Acquir Immune Defic Syndr; 2009 Feb; 50(2):168-75. PubMed ID: 19131892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
